5 Kidney Cancer Clinical Trials in Atlanta, GA (2026)

Q: How do I join a clinical trial in Atlanta?

Browse available studies, click one that interests you, and complete the free eligibility form. A study coordinator at the Atlanta research site will contact you.

Recruiting Kidney Cancer Studies in Atlanta

NCT05536141Recruiting

A Phase 1 Study of AB521 Monotherapy and Combination Therapies in Renal Cell Carcinoma and Other Solid Tumors

The purpose of this study is to evaluate the safety and tolerability of: * casdatifan when taken alone in participants with advanced solid tumor malignancies and clear cell renal cell carcinoma (ccRC...

Atlanta, GAPHASE1362 participantsArcus Biosciences, Inc.

View Study Details

NCT05433142Recruiting

Study of XmAb®819 in Subjects With Advanced Clear Cell Renal Cell Carcinoma

The purpose of this study is to assess the safety and tolerability of XmAb®819 administered intravenous (IV) or subcutaneous (SC) in subjects with relapsed or refractory clear cell renal cell carcinom...

Atlanta, GAPHASE1307 participantsXencor, Inc.

View Study Details

NCT07293351Recruiting

A Study to Evaluate the Safety, Tolerability, and Efficacy of Pumitamig Alone or in Combination With Ipilimumab or Cabozantinib in Participants With Advanced Renal Cell Carcinoma (RCC) (ROSETTA RCC-208)

The purpose of this study is to evaluate the safety, tolerability, and efficacy of Pumitamig alone or in combination with Ipilimumab or Cabozantinib in participants with advanced Renal Cell Carcinoma ...

Atlanta, GAPHASE1254 participantsBristol-Myers Squibb

View Study Details

NCT04620239Recruiting

ENdoluminal LIGHT ActivatED Treatment of Upper Tract Urothelial Cancer (ENLIGHTED) Study

This is a phase 3, open label, single arm study of padeliporfin in the treatment of Upper Tract Urothelial Carcinoma (UTUC). The ENLIGHTED study will recruit patients with low-grade non-invasive upper...

Atlanta, GAPHASE3100 participantsSteba Biotech S.A.

View Study Details

NCT04981509Recruiting

Testing of Bevacizumab, Erlotinib, and Atezolizumab in Combination for Advanced-Stage Kidney Cancer

This phase II trial studies the effects of combination therapy with bevacizumab, erlotinib, and atezolizumab in treating patients with hereditary leiomyomatosis and kidney cancer that may have spread ...

Atlanta, GAPHASE265 participantsNational Cancer Institute (NCI)

View Study Details

About Kidney Cancer Clinical Trials in Atlanta

Kidney cancer, most commonly renal cell carcinoma, develops in the lining of the kidney tubules. It accounts for about 3-5% of all adult cancers. Treatment includes surgery, targeted therapy, immunotherapy, and radiation.

There are currently 5 kidney cancer clinical trials recruiting participants in Atlanta, GA. These studies are seeking a combined 1,088 participants. Research is being sponsored by Arcus Biosciences, Inc., Xencor, Inc., Bristol-Myers Squibb and 2 other organizations. Clinical trial participation is free and participants receive study-related medical care at no cost.

Kidney Cancer Clinical Trials in Atlanta — FAQ

Are there kidney cancer clinical trials in Atlanta?

Yes, there are 5 kidney cancer clinical trials currently recruiting in Atlanta, GA. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Atlanta?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Atlanta research site will contact you about next steps.

Are clinical trials in Atlanta free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Atlanta studies also compensate for your time and travel.

What kidney cancer treatments are being tested?

The 5 active trials in Atlanta are testing new therapies including novel drugs, biologics, and treatment approaches for kidney cancer.

Data updated July 16, 2026 from ClinicalTrials.gov